nodes	percent_of_prediction	percent_of_DWPC	metapath
Desmopressin—PTGS2—Triamcinolone—psoriasis	0.171	0.424	CbGbCtD
Desmopressin—PTGS2—Betamethasone—psoriasis	0.147	0.364	CbGbCtD
Desmopressin—PTGS2—Dexamethasone—psoriasis	0.0853	0.212	CbGbCtD
Desmopressin—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	0.00227	0.157	CbGdCrCtD
Desmopressin—PTGS2—Fluocinonide—Beclomethasone—psoriasis	0.00182	0.126	CbGdCrCtD
Desmopressin—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.00176	0.122	CbGdCrCtD
Desmopressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.00166	0.0391	CbGpPWpGaD
Desmopressin—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.00137	0.0948	CbGdCrCtD
Desmopressin—AVPR1B—Peptide ligand-binding receptors—CCL20—psoriasis	0.00128	0.0302	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—HCAR2—psoriasis	0.00126	0.0297	CbGpPWpGaD
Desmopressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.00115	0.0271	CbGpPWpGaD
Desmopressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.00114	0.0269	CbGpPWpGaD
Desmopressin—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	0.0011	0.076	CbGdCrCtD
Desmopressin—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	0.0011	0.076	CbGdCrCtD
Desmopressin—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.00106	0.0738	CbGdCrCtD
Desmopressin—PTGS1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00106	0.025	CbGpPWpGaD
Desmopressin—AVPR1A—Peptide ligand-binding receptors—CCL20—psoriasis	0.000891	0.021	CbGpPWpGaD
Desmopressin—AVPR2—Peptide ligand-binding receptors—CCL20—psoriasis	0.000884	0.0208	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR ligand binding—HCAR2—psoriasis	0.000876	0.0206	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—HCAR2—psoriasis	0.00087	0.0205	CbGpPWpGaD
Desmopressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000862	0.0203	CbGpPWpGaD
Desmopressin—PTGS2—Fluocinonide—Betamethasone—psoriasis	0.000828	0.0574	CbGdCrCtD
Desmopressin—PTGS2—Fluocinonide—Dexamethasone—psoriasis	0.000828	0.0574	CbGdCrCtD
Desmopressin—PTGS2—Fluocinonide—Triamcinolone—psoriasis	0.000809	0.0561	CbGdCrCtD
Desmopressin—PTGS1—Overview of nanoparticle effects—CRP—psoriasis	0.000784	0.0185	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—HCAR2—psoriasis	0.000714	0.0168	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—CCL20—psoriasis	0.000656	0.0154	CbGpPWpGaD
Desmopressin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	0.000651	0.0153	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—HCAR2—psoriasis	0.000648	0.0153	CbGpPWpGaD
Desmopressin—PTGS2—Overview of nanoparticle effects—CRP—psoriasis	0.000623	0.0147	CbGpPWpGaD
Desmopressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000597	0.0141	CbGpPWpGaD
Desmopressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000593	0.014	CbGpPWpGaD
Desmopressin—PTGS1—Biological oxidations—CYP2S1—psoriasis	0.000564	0.0133	CbGpPWpGaD
Desmopressin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—psoriasis	0.000514	0.0121	CbGpPWpGaD
Desmopressin—PTGS1—Overview of nanoparticle effects—CXCL8—psoriasis	0.00051	0.012	CbGpPWpGaD
Desmopressin—PTGS2—Fluticasone Propionate—Dexamethasone—psoriasis	0.000499	0.0346	CbGdCrCtD
Desmopressin—PTGS2—Fluticasone Propionate—Betamethasone—psoriasis	0.000499	0.0346	CbGdCrCtD
Desmopressin—AVPR1A—GPCR downstream signaling—HCAR2—psoriasis	0.000495	0.0117	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—HCAR2—psoriasis	0.000491	0.0116	CbGpPWpGaD
Desmopressin—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	0.000488	0.0338	CbGdCrCtD
Desmopressin—AVPR1A—GPCR ligand binding—CCL20—psoriasis	0.000455	0.0107	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—CCL20—psoriasis	0.000452	0.0106	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—HCAR2—psoriasis	0.000449	0.0106	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—HCAR2—psoriasis	0.000446	0.0105	CbGpPWpGaD
Desmopressin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.000432	0.0102	CbGpPWpGaD
Desmopressin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000416	0.00979	CbGpPWpGaD
Desmopressin—PTGS2—Overview of nanoparticle effects—CXCL8—psoriasis	0.000405	0.00953	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—HCAR2—psoriasis	0.000383	0.00902	CbGpPWpGaD
Desmopressin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.000377	0.00888	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—CCL20—psoriasis	0.000371	0.00873	CbGpPWpGaD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.000361	0.0085	CbGpPWpGaD
Desmopressin—PTGS1—Overview of nanoparticle effects—TNF—psoriasis	0.000355	0.00836	CbGpPWpGaD
Desmopressin—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	0.000348	0.0082	CbGpPWpGaD
Desmopressin—AVPR1B—Peptide ligand-binding receptors—CXCL8—psoriasis	0.000347	0.00817	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—CCL20—psoriasis	0.000337	0.00793	CbGpPWpGaD
Desmopressin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—psoriasis	0.000332	0.00782	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TAGAP—psoriasis	0.000332	0.00782	CbGpPWpGaD
Desmopressin—PTGS2—S1P1 pathway—VEGFA—psoriasis	0.000329	0.00774	CbGpPWpGaD
Desmopressin—AVPR2—Transmembrane transport of small molecules—CP—psoriasis	0.000312	0.00734	CbGpPWpGaD
Desmopressin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—psoriasis	0.00031	0.00731	CbGpPWpGaD
Desmopressin—Hyperhidrosis—Triamcinolone—psoriasis	0.000306	0.000566	CcSEcCtD
Desmopressin—Convulsion—Dexamethasone—psoriasis	0.000304	0.000564	CcSEcCtD
Desmopressin—Convulsion—Betamethasone—psoriasis	0.000304	0.000564	CcSEcCtD
Desmopressin—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000304	0.000562	CcSEcCtD
Desmopressin—Insomnia—Hydrocortisone—psoriasis	0.000304	0.000562	CcSEcCtD
Desmopressin—Hypertension—Dexamethasone—psoriasis	0.000303	0.000562	CcSEcCtD
Desmopressin—Hypertension—Betamethasone—psoriasis	0.000303	0.000562	CcSEcCtD
Desmopressin—Paraesthesia—Hydrocortisone—psoriasis	0.000301	0.000558	CcSEcCtD
Desmopressin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000301	0.000558	CcSEcCtD
Desmopressin—Urticaria—Cyclosporine—psoriasis	0.0003	0.000556	CcSEcCtD
Desmopressin—Myalgia—Betamethasone—psoriasis	0.000299	0.000554	CcSEcCtD
Desmopressin—Myalgia—Dexamethasone—psoriasis	0.000299	0.000554	CcSEcCtD
Desmopressin—Abdominal pain—Cyclosporine—psoriasis	0.000299	0.000553	CcSEcCtD
Desmopressin—Body temperature increased—Cyclosporine—psoriasis	0.000299	0.000553	CcSEcCtD
Desmopressin—Anxiety—Dexamethasone—psoriasis	0.000298	0.000552	CcSEcCtD
Desmopressin—Anxiety—Betamethasone—psoriasis	0.000298	0.000552	CcSEcCtD
Desmopressin—AVPR2—Transmembrane transport of small molecules—CARM1—psoriasis	0.000297	0.007	CbGpPWpGaD
Desmopressin—Vomiting—Mycophenolic acid—psoriasis	0.000297	0.00055	CcSEcCtD
Desmopressin—Discomfort—Betamethasone—psoriasis	0.000296	0.000547	CcSEcCtD
Desmopressin—Discomfort—Dexamethasone—psoriasis	0.000296	0.000547	CcSEcCtD
Desmopressin—Dyspepsia—Hydrocortisone—psoriasis	0.000295	0.000547	CcSEcCtD
Desmopressin—Rash—Mycophenolic acid—psoriasis	0.000294	0.000545	CcSEcCtD
Desmopressin—Dermatitis—Mycophenolic acid—psoriasis	0.000294	0.000545	CcSEcCtD
Desmopressin—Pain—Prednisolone—psoriasis	0.000294	0.000544	CcSEcCtD
Desmopressin—Urticaria—Mycophenolate mofetil—psoriasis	0.000293	0.000542	CcSEcCtD
Desmopressin—Headache—Mycophenolic acid—psoriasis	0.000292	0.000542	CcSEcCtD
Desmopressin—Decreased appetite—Hydrocortisone—psoriasis	0.000292	0.00054	CcSEcCtD
Desmopressin—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000291	0.000539	CcSEcCtD
Desmopressin—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000291	0.000539	CcSEcCtD
Desmopressin—Urinary tract disorder—Methotrexate—psoriasis	0.00029	0.000537	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.00029	0.000537	CcSEcCtD
Desmopressin—PTGS1—Selenium Micronutrient Network—CAT—psoriasis	0.00029	0.00682	CbGpPWpGaD
Desmopressin—Fatigue—Hydrocortisone—psoriasis	0.000289	0.000536	CcSEcCtD
Desmopressin—Urethral disorder—Methotrexate—psoriasis	0.000288	0.000533	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000288	0.000533	CcSEcCtD
Desmopressin—Pain—Hydrocortisone—psoriasis	0.000287	0.000531	CcSEcCtD
Desmopressin—Anaphylactic shock—Dexamethasone—psoriasis	0.000287	0.000531	CcSEcCtD
Desmopressin—Oedema—Betamethasone—psoriasis	0.000287	0.000531	CcSEcCtD
Desmopressin—Oedema—Dexamethasone—psoriasis	0.000287	0.000531	CcSEcCtD
Desmopressin—Anaphylactic shock—Betamethasone—psoriasis	0.000287	0.000531	CcSEcCtD
Desmopressin—PTGS1—Overview of nanoparticle effects—IL6—psoriasis	0.000286	0.00674	CbGpPWpGaD
Desmopressin—Insomnia—Triamcinolone—psoriasis	0.000286	0.000529	CcSEcCtD
Desmopressin—Infection—Betamethasone—psoriasis	0.000285	0.000527	CcSEcCtD
Desmopressin—Infection—Dexamethasone—psoriasis	0.000285	0.000527	CcSEcCtD
Desmopressin—Ill-defined disorder—Prednisone—psoriasis	0.000284	0.000526	CcSEcCtD
Desmopressin—Paraesthesia—Triamcinolone—psoriasis	0.000284	0.000525	CcSEcCtD
Desmopressin—Feeling abnormal—Prednisolone—psoriasis	0.000283	0.000524	CcSEcCtD
Desmopressin—Visual impairment—Methotrexate—psoriasis	0.000283	0.000524	CcSEcCtD
Desmopressin—Shock—Betamethasone—psoriasis	0.000282	0.000522	CcSEcCtD
Desmopressin—Shock—Dexamethasone—psoriasis	0.000282	0.000522	CcSEcCtD
Desmopressin—PTGS2—Overview of nanoparticle effects—TNF—psoriasis	0.000282	0.00663	CbGpPWpGaD
Desmopressin—Dyspnoea—Triamcinolone—psoriasis	0.000282	0.000522	CcSEcCtD
Desmopressin—Nervous system disorder—Betamethasone—psoriasis	0.000281	0.000521	CcSEcCtD
Desmopressin—Nervous system disorder—Dexamethasone—psoriasis	0.000281	0.000521	CcSEcCtD
Desmopressin—Agitation—Prednisone—psoriasis	0.000281	0.000521	CcSEcCtD
Desmopressin—Tachycardia—Betamethasone—psoriasis	0.00028	0.000518	CcSEcCtD
Desmopressin—Tachycardia—Dexamethasone—psoriasis	0.00028	0.000518	CcSEcCtD
Desmopressin—Hypersensitivity—Cyclosporine—psoriasis	0.000278	0.000515	CcSEcCtD
Desmopressin—Dyspepsia—Triamcinolone—psoriasis	0.000278	0.000515	CcSEcCtD
Desmopressin—Nausea—Mycophenolic acid—psoriasis	0.000277	0.000513	CcSEcCtD
Desmopressin—Hyperhidrosis—Dexamethasone—psoriasis	0.000277	0.000513	CcSEcCtD
Desmopressin—Hyperhidrosis—Betamethasone—psoriasis	0.000277	0.000513	CcSEcCtD
Desmopressin—Feeling abnormal—Hydrocortisone—psoriasis	0.000277	0.000512	CcSEcCtD
Desmopressin—Malaise—Prednisone—psoriasis	0.000276	0.000511	CcSEcCtD
Desmopressin—Vertigo—Prednisone—psoriasis	0.000275	0.000509	CcSEcCtD
Desmopressin—Eye disorder—Methotrexate—psoriasis	0.000275	0.000508	CcSEcCtD
Desmopressin—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000275	0.000508	CcSEcCtD
Desmopressin—Syncope—Prednisone—psoriasis	0.000274	0.000508	CcSEcCtD
Desmopressin—Anorexia—Dexamethasone—psoriasis	0.000273	0.000506	CcSEcCtD
Desmopressin—Anorexia—Betamethasone—psoriasis	0.000273	0.000506	CcSEcCtD
Desmopressin—Urticaria—Prednisolone—psoriasis	0.000273	0.000506	CcSEcCtD
Desmopressin—Cardiac disorder—Methotrexate—psoriasis	0.000273	0.000505	CcSEcCtD
Desmopressin—Fatigue—Triamcinolone—psoriasis	0.000273	0.000505	CcSEcCtD
Desmopressin—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000271	0.000503	CcSEcCtD
Desmopressin—Asthenia—Cyclosporine—psoriasis	0.000271	0.000502	CcSEcCtD
Desmopressin—Pain—Triamcinolone—psoriasis	0.00027	0.0005	CcSEcCtD
Desmopressin—Loss of consciousness—Prednisone—psoriasis	0.000269	0.000498	CcSEcCtD
Desmopressin—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—psoriasis	0.000268	0.00632	CbGpPWpGaD
Desmopressin—Pruritus—Cyclosporine—psoriasis	0.000267	0.000495	CcSEcCtD
Desmopressin—Urticaria—Hydrocortisone—psoriasis	0.000267	0.000494	CcSEcCtD
Desmopressin—Angiopathy—Methotrexate—psoriasis	0.000267	0.000494	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—HCAR2—psoriasis	0.000266	0.00625	CbGpPWpGaD
Desmopressin—Immune system disorder—Methotrexate—psoriasis	0.000265	0.000491	CcSEcCtD
Desmopressin—Body temperature increased—Hydrocortisone—psoriasis	0.000265	0.000491	CcSEcCtD
Desmopressin—Abdominal pain—Hydrocortisone—psoriasis	0.000265	0.000491	CcSEcCtD
Desmopressin—Convulsion—Prednisone—psoriasis	0.000265	0.000491	CcSEcCtD
Desmopressin—Mediastinal disorder—Methotrexate—psoriasis	0.000265	0.00049	CcSEcCtD
Desmopressin—Asthenia—Mycophenolate mofetil—psoriasis	0.000264	0.000489	CcSEcCtD
Desmopressin—Hypertension—Prednisone—psoriasis	0.000264	0.000489	CcSEcCtD
Desmopressin—Chills—Methotrexate—psoriasis	0.000264	0.000488	CcSEcCtD
Desmopressin—AVPR2—Signaling Pathways—HCAR2—psoriasis	0.000264	0.00621	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000262	0.00616	CbGpPWpGaD
Desmopressin—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000261	0.000484	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000261	0.000484	CcSEcCtD
Desmopressin—Pruritus—Mycophenolate mofetil—psoriasis	0.000261	0.000483	CcSEcCtD
Desmopressin—Myalgia—Prednisone—psoriasis	0.000261	0.000482	CcSEcCtD
Desmopressin—Feeling abnormal—Triamcinolone—psoriasis	0.00026	0.000482	CcSEcCtD
Desmopressin—Anxiety—Prednisone—psoriasis	0.00026	0.000481	CcSEcCtD
Desmopressin—Insomnia—Betamethasone—psoriasis	0.000259	0.00048	CcSEcCtD
Desmopressin—Insomnia—Dexamethasone—psoriasis	0.000259	0.00048	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000259	0.000479	CcSEcCtD
Desmopressin—Diarrhoea—Cyclosporine—psoriasis	0.000258	0.000478	CcSEcCtD
Desmopressin—Paraesthesia—Betamethasone—psoriasis	0.000258	0.000477	CcSEcCtD
Desmopressin—Paraesthesia—Dexamethasone—psoriasis	0.000258	0.000477	CcSEcCtD
Desmopressin—Discomfort—Prednisone—psoriasis	0.000257	0.000477	CcSEcCtD
Desmopressin—Mental disorder—Methotrexate—psoriasis	0.000257	0.000477	CcSEcCtD
Desmopressin—AVPR1A—GPCR downstream signaling—CCL20—psoriasis	0.000257	0.00605	CbGpPWpGaD
Desmopressin—Erythema—Methotrexate—psoriasis	0.000256	0.000474	CcSEcCtD
Desmopressin—Malnutrition—Methotrexate—psoriasis	0.000256	0.000474	CcSEcCtD
Desmopressin—AVPR2—GPCR downstream signaling—CCL20—psoriasis	0.000255	0.00601	CbGpPWpGaD
Desmopressin—Hypersensitivity—Prednisolone—psoriasis	0.000253	0.000469	CcSEcCtD
Desmopressin—Dyspepsia—Dexamethasone—psoriasis	0.000252	0.000467	CcSEcCtD
Desmopressin—Dyspepsia—Betamethasone—psoriasis	0.000252	0.000467	CcSEcCtD
Desmopressin—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000252	0.000467	CcSEcCtD
Desmopressin—Urticaria—Triamcinolone—psoriasis	0.000251	0.000465	CcSEcCtD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.00025	0.00589	CbGpPWpGaD
Desmopressin—Body temperature increased—Triamcinolone—psoriasis	0.00025	0.000463	CcSEcCtD
Desmopressin—Dizziness—Cyclosporine—psoriasis	0.00025	0.000462	CcSEcCtD
Desmopressin—Oedema—Prednisone—psoriasis	0.00025	0.000462	CcSEcCtD
Desmopressin—Anaphylactic shock—Prednisone—psoriasis	0.00025	0.000462	CcSEcCtD
Desmopressin—Decreased appetite—Betamethasone—psoriasis	0.000249	0.000462	CcSEcCtD
Desmopressin—Decreased appetite—Dexamethasone—psoriasis	0.000249	0.000462	CcSEcCtD
Desmopressin—Infection—Prednisone—psoriasis	0.000248	0.000459	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000248	0.000458	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Betamethasone—psoriasis	0.000248	0.000458	CcSEcCtD
Desmopressin—Hypersensitivity—Hydrocortisone—psoriasis	0.000247	0.000458	CcSEcCtD
Desmopressin—Fatigue—Betamethasone—psoriasis	0.000247	0.000458	CcSEcCtD
Desmopressin—Fatigue—Dexamethasone—psoriasis	0.000247	0.000458	CcSEcCtD
Desmopressin—Shock—Prednisone—psoriasis	0.000246	0.000455	CcSEcCtD
Desmopressin—Pain—Betamethasone—psoriasis	0.000245	0.000454	CcSEcCtD
Desmopressin—Pain—Dexamethasone—psoriasis	0.000245	0.000454	CcSEcCtD
Desmopressin—Nervous system disorder—Prednisone—psoriasis	0.000245	0.000453	CcSEcCtD
Desmopressin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—psoriasis	0.000245	0.00576	CbGpPWpGaD
Desmopressin—Tachycardia—Prednisone—psoriasis	0.000244	0.000451	CcSEcCtD
Desmopressin—Dizziness—Mycophenolate mofetil—psoriasis	0.000244	0.000451	CcSEcCtD
Desmopressin—Skin disorder—Prednisone—psoriasis	0.000243	0.000449	CcSEcCtD
Desmopressin—Hyperhidrosis—Prednisone—psoriasis	0.000241	0.000447	CcSEcCtD
Desmopressin—Asthenia—Hydrocortisone—psoriasis	0.000241	0.000446	CcSEcCtD
Desmopressin—AVPR1A—Peptide ligand-binding receptors—CXCL8—psoriasis	0.000241	0.00566	CbGpPWpGaD
Desmopressin—Vomiting—Cyclosporine—psoriasis	0.00024	0.000445	CcSEcCtD
Desmopressin—AVPR2—Peptide ligand-binding receptors—CXCL8—psoriasis	0.000239	0.00562	CbGpPWpGaD
Desmopressin—Rash—Cyclosporine—psoriasis	0.000238	0.000441	CcSEcCtD
Desmopressin—Anorexia—Prednisone—psoriasis	0.000238	0.000441	CcSEcCtD
Desmopressin—Dermatitis—Cyclosporine—psoriasis	0.000238	0.000441	CcSEcCtD
Desmopressin—Pruritus—Hydrocortisone—psoriasis	0.000237	0.00044	CcSEcCtD
Desmopressin—Ill-defined disorder—Methotrexate—psoriasis	0.000237	0.000439	CcSEcCtD
Desmopressin—Headache—Cyclosporine—psoriasis	0.000237	0.000438	CcSEcCtD
Desmopressin—Feeling abnormal—Betamethasone—psoriasis	0.000236	0.000438	CcSEcCtD
Desmopressin—Feeling abnormal—Dexamethasone—psoriasis	0.000236	0.000438	CcSEcCtD
Desmopressin—Gastrointestinal pain—Betamethasone—psoriasis	0.000235	0.000434	CcSEcCtD
Desmopressin—Gastrointestinal pain—Dexamethasone—psoriasis	0.000235	0.000434	CcSEcCtD
Desmopressin—Vomiting—Mycophenolate mofetil—psoriasis	0.000234	0.000434	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—CCL20—psoriasis	0.000233	0.0055	CbGpPWpGaD
Desmopressin—Hypersensitivity—Triamcinolone—psoriasis	0.000233	0.000431	CcSEcCtD
Desmopressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000233	0.00548	CbGpPWpGaD
Desmopressin—Rash—Mycophenolate mofetil—psoriasis	0.000232	0.00043	CcSEcCtD
Desmopressin—Dermatitis—Mycophenolate mofetil—psoriasis	0.000232	0.00043	CcSEcCtD
Desmopressin—AVPR2—Signaling by GPCR—CCL20—psoriasis	0.000232	0.00546	CbGpPWpGaD
Desmopressin—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	0.000231	0.00543	CbGpPWpGaD
Desmopressin—Headache—Mycophenolate mofetil—psoriasis	0.000231	0.000427	CcSEcCtD
Desmopressin—Malaise—Methotrexate—psoriasis	0.000231	0.000427	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—TAGAP—psoriasis	0.00023	0.00542	CbGpPWpGaD
Desmopressin—PTGS1—Selenium Micronutrient Network—CRP—psoriasis	0.00023	0.00542	CbGpPWpGaD
Desmopressin—PTGS2—Selenium Micronutrient Network—CAT—psoriasis	0.00023	0.00541	CbGpPWpGaD
Desmopressin—Vertigo—Methotrexate—psoriasis	0.00023	0.000425	CcSEcCtD
Desmopressin—Diarrhoea—Hydrocortisone—psoriasis	0.00023	0.000425	CcSEcCtD
Desmopressin—AVPR2—Signaling Pathways—TAGAP—psoriasis	0.000229	0.00538	CbGpPWpGaD
Desmopressin—Urticaria—Dexamethasone—psoriasis	0.000228	0.000422	CcSEcCtD
Desmopressin—Urticaria—Betamethasone—psoriasis	0.000228	0.000422	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Prednisone—psoriasis	0.000228	0.000421	CcSEcCtD
Desmopressin—PTGS2—Overview of nanoparticle effects—IL6—psoriasis	0.000227	0.00535	CbGpPWpGaD
Desmopressin—Dizziness—Prednisolone—psoriasis	0.000227	0.000421	CcSEcCtD
Desmopressin—Asthenia—Triamcinolone—psoriasis	0.000227	0.00042	CcSEcCtD
Desmopressin—Abdominal pain—Betamethasone—psoriasis	0.000227	0.00042	CcSEcCtD
Desmopressin—Abdominal pain—Dexamethasone—psoriasis	0.000227	0.00042	CcSEcCtD
Desmopressin—Body temperature increased—Betamethasone—psoriasis	0.000227	0.00042	CcSEcCtD
Desmopressin—Body temperature increased—Dexamethasone—psoriasis	0.000227	0.00042	CcSEcCtD
Desmopressin—Insomnia—Prednisone—psoriasis	0.000226	0.000418	CcSEcCtD
Desmopressin—Nausea—Cyclosporine—psoriasis	0.000224	0.000415	CcSEcCtD
Desmopressin—Paraesthesia—Prednisone—psoriasis	0.000224	0.000415	CcSEcCtD
Desmopressin—Pruritus—Triamcinolone—psoriasis	0.000224	0.000414	CcSEcCtD
Desmopressin—Cough—Methotrexate—psoriasis	0.000223	0.000413	CcSEcCtD
Desmopressin—Dizziness—Hydrocortisone—psoriasis	0.000222	0.000411	CcSEcCtD
Desmopressin—Convulsion—Methotrexate—psoriasis	0.000222	0.00041	CcSEcCtD
Desmopressin—Dyspepsia—Prednisone—psoriasis	0.00022	0.000407	CcSEcCtD
Desmopressin—Nausea—Mycophenolate mofetil—psoriasis	0.000219	0.000405	CcSEcCtD
Desmopressin—Chest pain—Methotrexate—psoriasis	0.000218	0.000403	CcSEcCtD
Desmopressin—Myalgia—Methotrexate—psoriasis	0.000218	0.000403	CcSEcCtD
Desmopressin—Decreased appetite—Prednisone—psoriasis	0.000217	0.000402	CcSEcCtD
Desmopressin—Rash—Prednisolone—psoriasis	0.000217	0.000401	CcSEcCtD
Desmopressin—Dermatitis—Prednisolone—psoriasis	0.000217	0.000401	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000216	0.0004	CcSEcCtD
Desmopressin—Fatigue—Prednisone—psoriasis	0.000215	0.000399	CcSEcCtD
Desmopressin—Headache—Prednisolone—psoriasis	0.000215	0.000399	CcSEcCtD
Desmopressin—Discomfort—Methotrexate—psoriasis	0.000215	0.000398	CcSEcCtD
Desmopressin—Constipation—Prednisone—psoriasis	0.000214	0.000395	CcSEcCtD
Desmopressin—Vomiting—Hydrocortisone—psoriasis	0.000213	0.000395	CcSEcCtD
Desmopressin—Rash—Hydrocortisone—psoriasis	0.000212	0.000392	CcSEcCtD
Desmopressin—PTGS1—Selenium Micronutrient Network—ICAM1—psoriasis	0.000211	0.00498	CbGpPWpGaD
Desmopressin—Dermatitis—Hydrocortisone—psoriasis	0.000211	0.000391	CcSEcCtD
Desmopressin—Confusional state—Methotrexate—psoriasis	0.00021	0.00039	CcSEcCtD
Desmopressin—Headache—Hydrocortisone—psoriasis	0.00021	0.000389	CcSEcCtD
Desmopressin—Dizziness—Triamcinolone—psoriasis	0.000209	0.000387	CcSEcCtD
Desmopressin—Anaphylactic shock—Methotrexate—psoriasis	0.000209	0.000386	CcSEcCtD
Desmopressin—Infection—Methotrexate—psoriasis	0.000207	0.000384	CcSEcCtD
Desmopressin—Feeling abnormal—Prednisone—psoriasis	0.000206	0.000381	CcSEcCtD
Desmopressin—Asthenia—Dexamethasone—psoriasis	0.000206	0.000381	CcSEcCtD
Desmopressin—Asthenia—Betamethasone—psoriasis	0.000206	0.000381	CcSEcCtD
Desmopressin—Nervous system disorder—Methotrexate—psoriasis	0.000205	0.000379	CcSEcCtD
Desmopressin—Gastrointestinal pain—Prednisone—psoriasis	0.000204	0.000378	CcSEcCtD
Desmopressin—Nausea—Prednisolone—psoriasis	0.000204	0.000378	CcSEcCtD
Desmopressin—Pruritus—Betamethasone—psoriasis	0.000203	0.000376	CcSEcCtD
Desmopressin—Pruritus—Dexamethasone—psoriasis	0.000203	0.000376	CcSEcCtD
Desmopressin—Skin disorder—Methotrexate—psoriasis	0.000203	0.000375	CcSEcCtD
Desmopressin—Hyperhidrosis—Methotrexate—psoriasis	0.000202	0.000374	CcSEcCtD
Desmopressin—Vomiting—Triamcinolone—psoriasis	0.000201	0.000372	CcSEcCtD
Desmopressin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—psoriasis	0.000201	0.00473	CbGpPWpGaD
Desmopressin—Nausea—Hydrocortisone—psoriasis	0.000199	0.000369	CcSEcCtD
Desmopressin—Rash—Triamcinolone—psoriasis	0.000199	0.000369	CcSEcCtD
Desmopressin—Dermatitis—Triamcinolone—psoriasis	0.000199	0.000369	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—CCL20—psoriasis	0.000199	0.00468	CbGpPWpGaD
Desmopressin—Anorexia—Methotrexate—psoriasis	0.000199	0.000368	CcSEcCtD
Desmopressin—Urticaria—Prednisone—psoriasis	0.000198	0.000367	CcSEcCtD
Desmopressin—Headache—Triamcinolone—psoriasis	0.000198	0.000367	CcSEcCtD
Desmopressin—Abdominal pain—Prednisone—psoriasis	0.000197	0.000366	CcSEcCtD
Desmopressin—Body temperature increased—Prednisone—psoriasis	0.000197	0.000366	CcSEcCtD
Desmopressin—Diarrhoea—Dexamethasone—psoriasis	0.000196	0.000363	CcSEcCtD
Desmopressin—Diarrhoea—Betamethasone—psoriasis	0.000196	0.000363	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Methotrexate—psoriasis	0.00019	0.000352	CcSEcCtD
Desmopressin—Dizziness—Betamethasone—psoriasis	0.00019	0.000351	CcSEcCtD
Desmopressin—Dizziness—Dexamethasone—psoriasis	0.00019	0.000351	CcSEcCtD
Desmopressin—Insomnia—Methotrexate—psoriasis	0.000189	0.00035	CcSEcCtD
Desmopressin—Nausea—Triamcinolone—psoriasis	0.000188	0.000348	CcSEcCtD
Desmopressin—Paraesthesia—Methotrexate—psoriasis	0.000187	0.000347	CcSEcCtD
Desmopressin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—psoriasis	0.000187	0.00439	CbGpPWpGaD
Desmopressin—Dyspnoea—Methotrexate—psoriasis	0.000186	0.000345	CcSEcCtD
Desmopressin—Somnolence—Methotrexate—psoriasis	0.000186	0.000344	CcSEcCtD
Desmopressin—Hypersensitivity—Prednisone—psoriasis	0.000184	0.000341	CcSEcCtD
Desmopressin—Dyspepsia—Methotrexate—psoriasis	0.000184	0.00034	CcSEcCtD
Desmopressin—PTGS2—Selenium Micronutrient Network—CRP—psoriasis	0.000183	0.0043	CbGpPWpGaD
Desmopressin—Vomiting—Betamethasone—psoriasis	0.000182	0.000338	CcSEcCtD
Desmopressin—Vomiting—Dexamethasone—psoriasis	0.000182	0.000338	CcSEcCtD
Desmopressin—Decreased appetite—Methotrexate—psoriasis	0.000181	0.000336	CcSEcCtD
Desmopressin—Rash—Dexamethasone—psoriasis	0.000181	0.000335	CcSEcCtD
Desmopressin—Rash—Betamethasone—psoriasis	0.000181	0.000335	CcSEcCtD
Desmopressin—Dermatitis—Dexamethasone—psoriasis	0.000181	0.000334	CcSEcCtD
Desmopressin—Dermatitis—Betamethasone—psoriasis	0.000181	0.000334	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Methotrexate—psoriasis	0.00018	0.000334	CcSEcCtD
Desmopressin—Fatigue—Methotrexate—psoriasis	0.00018	0.000333	CcSEcCtD
Desmopressin—Headache—Betamethasone—psoriasis	0.00018	0.000333	CcSEcCtD
Desmopressin—Headache—Dexamethasone—psoriasis	0.00018	0.000333	CcSEcCtD
Desmopressin—Asthenia—Prednisone—psoriasis	0.000179	0.000332	CcSEcCtD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.000179	0.0042	CbGpPWpGaD
Desmopressin—Pain—Methotrexate—psoriasis	0.000179	0.00033	CcSEcCtD
Desmopressin—AVPR1B—GPCR ligand binding—CXCL8—psoriasis	0.000177	0.00417	CbGpPWpGaD
Desmopressin—Pruritus—Prednisone—psoriasis	0.000177	0.000327	CcSEcCtD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.000177	0.00416	CbGpPWpGaD
Desmopressin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—psoriasis	0.000174	0.00409	CbGpPWpGaD
Desmopressin—Feeling abnormal—Methotrexate—psoriasis	0.000172	0.000318	CcSEcCtD
Desmopressin—Diarrhoea—Prednisone—psoriasis	0.000171	0.000316	CcSEcCtD
Desmopressin—Gastrointestinal pain—Methotrexate—psoriasis	0.000171	0.000316	CcSEcCtD
Desmopressin—Nausea—Dexamethasone—psoriasis	0.00017	0.000315	CcSEcCtD
Desmopressin—Nausea—Betamethasone—psoriasis	0.00017	0.000315	CcSEcCtD
Desmopressin—PTGS2—Selenium Micronutrient Network—ICAM1—psoriasis	0.000168	0.00395	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—IL4—psoriasis	0.000167	0.00393	CbGpPWpGaD
Desmopressin—Urticaria—Methotrexate—psoriasis	0.000166	0.000307	CcSEcCtD
Desmopressin—Dizziness—Prednisone—psoriasis	0.000165	0.000306	CcSEcCtD
Desmopressin—Abdominal pain—Methotrexate—psoriasis	0.000165	0.000305	CcSEcCtD
Desmopressin—Body temperature increased—Methotrexate—psoriasis	0.000165	0.000305	CcSEcCtD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.000162	0.00382	CbGpPWpGaD
Desmopressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000161	0.0038	CbGpPWpGaD
Desmopressin—PTGS1—Selenium Micronutrient Network—IFNG—psoriasis	0.000161	0.00379	CbGpPWpGaD
Desmopressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.00016	0.00377	CbGpPWpGaD
Desmopressin—Vomiting—Prednisone—psoriasis	0.000159	0.000294	CcSEcCtD
Desmopressin—Rash—Prednisone—psoriasis	0.000157	0.000292	CcSEcCtD
Desmopressin—Dermatitis—Prednisone—psoriasis	0.000157	0.000291	CcSEcCtD
Desmopressin—Headache—Prednisone—psoriasis	0.000156	0.00029	CcSEcCtD
Desmopressin—Hypersensitivity—Methotrexate—psoriasis	0.000154	0.000285	CcSEcCtD
Desmopressin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	0.000152	0.00359	CbGpPWpGaD
Desmopressin—Asthenia—Methotrexate—psoriasis	0.00015	0.000277	CcSEcCtD
Desmopressin—Nausea—Prednisone—psoriasis	0.000148	0.000275	CcSEcCtD
Desmopressin—Pruritus—Methotrexate—psoriasis	0.000148	0.000273	CcSEcCtD
Desmopressin—Diarrhoea—Methotrexate—psoriasis	0.000143	0.000264	CcSEcCtD
Desmopressin—PTGS2—Spinal Cord Injury—LEP—psoriasis	0.000141	0.00333	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—TNF—psoriasis	0.000139	0.00327	CbGpPWpGaD
Desmopressin—Dizziness—Methotrexate—psoriasis	0.000138	0.000256	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—CCL20—psoriasis	0.000138	0.00325	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CCL20—psoriasis	0.000137	0.00322	CbGpPWpGaD
Desmopressin—PTGS1—Selenium Micronutrient Network—NFKB1—psoriasis	0.000134	0.00315	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—ICAM1—psoriasis	0.000133	0.00313	CbGpPWpGaD
Desmopressin—Vomiting—Methotrexate—psoriasis	0.000133	0.000246	CcSEcCtD
Desmopressin—PTGS2—Spinal Cord Injury—NOS2—psoriasis	0.000132	0.0031	CbGpPWpGaD
Desmopressin—Rash—Methotrexate—psoriasis	0.000132	0.000244	CcSEcCtD
Desmopressin—Dermatitis—Methotrexate—psoriasis	0.000131	0.000243	CcSEcCtD
Desmopressin—Headache—Methotrexate—psoriasis	0.000131	0.000242	CcSEcCtD
Desmopressin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriasis	0.00013	0.00306	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—CD4—psoriasis	0.000128	0.00301	CbGpPWpGaD
Desmopressin—PTGS2—Selenium Micronutrient Network—IFNG—psoriasis	0.000128	0.00301	CbGpPWpGaD
Desmopressin—Nausea—Methotrexate—psoriasis	0.000124	0.00023	CcSEcCtD
Desmopressin—AVPR1A—GPCR ligand binding—CXCL8—psoriasis	0.000123	0.00289	CbGpPWpGaD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.000122	0.00288	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—CXCL8—psoriasis	0.000122	0.00287	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NDUFA5—psoriasis	0.000114	0.00267	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—SOCS1—psoriasis	0.00011	0.00258	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.000107	0.00251	CbGpPWpGaD
Desmopressin—PTGS2—Selenium Micronutrient Network—NFKB1—psoriasis	0.000106	0.0025	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000106	0.00249	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—TYK2—psoriasis	0.000104	0.00246	CbGpPWpGaD
Desmopressin—PTGS1—Selenium Micronutrient Network—TNF—psoriasis	0.000104	0.00245	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—IFNG—psoriasis	0.000101	0.00238	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—CXCL8—psoriasis	0.0001	0.00236	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP2S1—psoriasis	9.65e-05	0.00227	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—CXCL8—psoriasis	9.39e-05	0.00221	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—CXCL8—psoriasis	9.1e-05	0.00214	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NDUFA5—psoriasis	9.01e-05	0.00212	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	8.96e-05	0.00211	CbGpPWpGaD
Desmopressin—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	8.4e-05	0.00198	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.4e-05	0.00198	CbGpPWpGaD
Desmopressin—PTGS2—Selenium Micronutrient Network—TNF—psoriasis	8.27e-05	0.00195	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—LEP—psoriasis	8.09e-05	0.0019	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—APOE—psoriasis	8.09e-05	0.0019	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP2S1—psoriasis	7.66e-05	0.0018	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—SOCS1—psoriasis	7.59e-05	0.00179	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—SOCS1—psoriasis	7.54e-05	0.00177	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—NFKBIA—psoriasis	7.53e-05	0.00177	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—TYK2—psoriasis	7.24e-05	0.0017	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—TYK2—psoriasis	7.19e-05	0.00169	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—CXCL8—psoriasis	6.94e-05	0.00163	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—CXCL8—psoriasis	6.89e-05	0.00162	CbGpPWpGaD
Desmopressin—PTGS2—Selenium Micronutrient Network—IL6—psoriasis	6.67e-05	0.00157	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—TNF—psoriasis	6.54e-05	0.00154	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—CXCL8—psoriasis	6.3e-05	0.00148	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—CXCL8—psoriasis	6.26e-05	0.00147	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TYK2—psoriasis	6.17e-05	0.00145	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	5.94e-05	0.0014	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—TP53—psoriasis	5.76e-05	0.00136	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	5.72e-05	0.00135	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—APOE—psoriasis	5.6e-05	0.00132	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—LEP—psoriasis	5.6e-05	0.00132	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—LEP—psoriasis	5.56e-05	0.00131	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—APOE—psoriasis	5.56e-05	0.00131	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CXCL8—psoriasis	5.37e-05	0.00126	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—IL6—psoriasis	5.28e-05	0.00124	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—NFKBIA—psoriasis	5.22e-05	0.00123	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	5.19e-05	0.00122	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—NFKBIA—psoriasis	5.19e-05	0.00122	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—IL6—psoriasis	5.11e-05	0.0012	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.06e-05	0.00119	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—JUN—psoriasis	5e-05	0.00118	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—NFKB1—psoriasis	4.81e-05	0.00113	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CARM1—psoriasis	4.71e-05	0.00111	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.45e-05	0.00105	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.41e-05	0.00104	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—VEGFA—psoriasis	4.36e-05	0.00103	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—STAT3—psoriasis	4.32e-05	0.00102	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TYK2—psoriasis	4.28e-05	0.00101	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TYK2—psoriasis	4.25e-05	0.001	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.02e-05	0.000945	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.92e-05	0.000923	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CARM1—psoriasis	3.74e-05	0.000881	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CXCL8—psoriasis	3.72e-05	0.000877	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CXCL8—psoriasis	3.7e-05	0.00087	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—IL6—psoriasis	3.54e-05	0.000834	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—IL6—psoriasis	3.52e-05	0.000828	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.5e-05	0.000823	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—JUN—psoriasis	3.46e-05	0.000815	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—JUN—psoriasis	3.44e-05	0.000809	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—NFKB1—psoriasis	3.33e-05	0.000785	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—NFKB1—psoriasis	3.31e-05	0.000779	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TP53—psoriasis	3.3e-05	0.000776	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—VEGFA—psoriasis	3.02e-05	0.000712	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—IL6—psoriasis	3.02e-05	0.00071	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—VEGFA—psoriasis	3e-05	0.000707	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—STAT3—psoriasis	3e-05	0.000705	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—STAT3—psoriasis	2.97e-05	0.0007	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CAT—psoriasis	2.9e-05	0.000682	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CAT—psoriasis	2.3e-05	0.000542	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HLA-A—psoriasis	2.29e-05	0.000538	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TP53—psoriasis	2.29e-05	0.000538	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TP53—psoriasis	2.27e-05	0.000534	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—APOE—psoriasis	2.25e-05	0.00053	CbGpPWpGaD
Desmopressin—PTGS2—Disease—APOE—psoriasis	2.14e-05	0.000503	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—IL6—psoriasis	2.09e-05	0.000492	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—IL6—psoriasis	2.08e-05	0.000489	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NOS2—psoriasis	1.99e-05	0.000468	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PPARG—psoriasis	1.96e-05	0.000462	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—APOE—psoriasis	1.79e-05	0.000421	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TYK2—psoriasis	1.63e-05	0.000384	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PPARG—psoriasis	1.56e-05	0.000367	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CD4—psoriasis	1.47e-05	0.000347	CbGpPWpGaD
Desmopressin—PTGS2—Disease—STAT3—psoriasis	1.14e-05	0.000269	CbGpPWpGaD
Desmopressin—PTGS2—Disease—IL6—psoriasis	7.97e-06	0.000188	CbGpPWpGaD
